Date updated:01-27-2009
Here are some charts of small cap stocsk that are displaying some interesting patterns and might be setting up to make a big move. Put these stocks on your radar..

-
CSIQ
Canadian Solar In - $17.04
- -0.35%
- $17.10
Canadian Solar(CSI) designs, develops, manufactures and sells solar cell and module products that convert sunlight into electricity for a variety of uses. This stock saw a gigantic spike in volume two days ago at over 4 million shares, vs. the 30-day average volume of 2,605,000 shares. CSIQ is approaching the 50-day moving average ($5.56) and if it can break through that level it could see a run back to $7-$7.50 a share.

-
TMTA
N/a - $17.52
- 0.00
- $17.52
Transmeta Corporation (TMTA) develops and licenses computing, microprocessor and semiconductor technologies and related intellectual property. This stock is in an unbelievably strong uptrend. Watch for TMTA to break above around $21 a share for signs of another big move higher.

-
STEM
Stemcells - $1.11
- -2.63%
- $1.14
StemCells (STEM) is a biopharmaceutical company. The Company is engaged in the discovery and development of cell-based therapeutics to treat damage to, or degeneration of, major organ systems. STEM has seen a huge run from around $1.40 to $3.00 after investors jumped in to ride the Geron (GERN) hype. This stock could be now setting up for a big fall and its worth nothing that shares weren't able to get above 3-year resistance at $3.63.

-
PALM
Palm - $10.99
- -0.45%
- $11.02
Palm (Palm) is a provider of mobile products. It offers Treo and Centro smartphones, handheld computers and accessories through a network of wireless carriers, as well as retail and business outlets worldwide. Shares of PALM were unable to break above previous resistance at around $9 a share. Watch for this stock to pullback to the 200-day moving average at $5.41 a share.

-
NABI
Nabi Biopharmaceu - $3.51
- -1.40%
- $3.61
Nabi Biopharmaceuticals is a biopharmaceutical company focused on the development of products in the areas of nicotine addiction and infectious disease. The stock is approaching the 200-day moving average ($4.23). Watch how the stock acts at this level - if it breaks above the 200-day a run to $4.75-$5.75 is in the cards.
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- » rk00005
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...
By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...
By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some stocks that moved up on unusual volume on Nov. 2, 2009. more
Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more
Analyst Downgrades for Nov. 2, 2009. Read more here. more











Comments not available